Anokion SA Announces Advancement in Celiac Drug Study
Anokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingAnokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.
Continue ReadingFody Food Co. announces its continued support of the Celiac Disease Foundation and the celiac community with its wide range of certified gluten-free and Low Fodmap products.
Continue ReadingThe ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.
Continue ReadingWe are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.
Continue ReadingRep. Betty McCollum (D-MN) and Rep. Steve Stivers (D-OH) announced the formation of the Congressional Celiac Disease Caucus at the 2021 Celiac Disease Foundation Patient Education & Advocacy Summit.
Continue ReadingHear from the Foundation’s CEO, Marilyn G. Geller, on today’s episode of the Celiac Project Podcast! Learn all about our groundbreaking Patient Education and Advocacy Summit, the monumental ways CDF is helping to advance legislation and research for celiac disease.
Continue ReadingThe Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.
Continue ReadingThank you to Labcorp for sponsoring our upcoming Patient Education and Advocacy Summit. Labcorp is a global life sciences company that brings diagnostic testing and drug development together. Register now!
Continue ReadingThank you to Takeda for sponsoring our upcoming Patient Education and Advocacy Summit. With nearly 30 years of experience in gastroenterology, Takeda has made significant strides toward closing the gap on unmet needs for patients who have celiac disease. Register now to be a part of this momentous event
Continue ReadingThank you to 9 Meters for sponsoring our upcoming Patient Education and Advocacy Summit. 9 Meters is a gastroenterology-focused therapeutics company targeting GI diseases with unmet needs. Register now! Celiac.org/summit
Continue Reading